Precedent Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.88M Buy
15,259
+2,419
+19% +$564K 0.64% 49
2026
Q1
$3.14M Buy
12,840
+629
+5% +$147K 0.63% 52
2025
Q4
$2.53M Buy
12,211
+380
+3% +$75.1K 0.53% 62
2025
Q3
$2.19M Buy
11,831
+782
+7% +$134K 0.48% 61
2025
Q2
$1.69M Buy
11,049
+1,489
+16% +$229K 0.41% 71
2025
Q1
$1.59M Buy
9,560
+1,836
+24% +$287K 0.44% 69
2024
Q4
$1.12M Buy
7,724
+123
+2% +$19.1K 0.36% 81
2024
Q3
$1.23M Buy
7,601
+470
+7% +$74.9K 0.41% 68
2024
Q2
$1.04M Buy
7,131
+630
+10% +$93.7K 0.42% 67
2024
Q1
$1.03M Buy
6,501
+564
+9% +$89.8K 0.44% 59
2023
Q4
$931K Buy
+5,937
New +$910K 0.47% 48

Other funds holding JNJ

Precedent Wealth Partners's JNJ Position: Q2 2026 in Review

Precedent Wealth Partners increased its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, buying an estimated $564K and bringing the position to 15,259 shares worth $3.88M. The position accounts for 0.64% of the portfolio, ranked #49.

Precedent Wealth Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Precedent Wealth Partners held 15,259 shares of Johnson & Johnson worth $3.88M as of Q2 2026.
  • Precedent Wealth Partners bought 2,419 Johnson & Johnson shares in Q2 2026, an estimated $564K.
  • Johnson & Johnson made up 0.64% of Precedent Wealth Partners's portfolio in Q2 2026, its #49 holding.
  • Precedent Wealth Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Precedent Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.